-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Initiates Coverage On Pharming with Buy Rating, Announces Price Target of $37

Benzinga·04/10/2026 12:05:59
Listen to the news
Canaccord Genuity analyst Whitney Ijem initiates coverage on Pharming (NASDAQ:PHAR) with a Buy rating and announces Price Target of $37.